The global market for Peripherally Inserted Central Catheters was valued at US$868.3 Million in 2025 and is projected to reach US$1.1 Billion by 2032, growing at a CAGR of 3.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
One of the key shifts favoring PICCs is their ability to be inserted at the bedside by specially trained nursing staff, eliminating the need for surgical suite occupancy and reducing procedural delays. Additionally, ultrasound and ECG-guided placement technologies have significantly enhanced insertion accuracy and safety, minimizing complications such as pneumothorax, arterial puncture, and catheter malposition. These benefits, combined with lower insertion costs and improved patient comfort, are propelling PICCs as the preferred vascular access method in both inpatient and outpatient care settings.
Stratified care pathways are also influencing PICC usage patterns. In oncology, PICCs offer a central line alternative that reduces the risk of thrombosis and facilitates outpatient chemotherapy regimens. In home infusion therapy, patients with chronic infections or gastrointestinal disorders are now managed via PICCs supported by mobile care teams, improving continuity and reducing hospital readmission rates. Clinical algorithms based on dwell time, infusion type, and venous condition are increasingly guiding vascular access decisions, leading to more targeted and efficient use of PICCs.
Integrated care models are also playing a key role in expanding the PICC market. Hospitals are establishing dedicated vascular access teams that streamline PICC placement, maintenance, and removal protocols, thus standardizing best practices and reducing complication rates. In ambulatory care and long-term acute care settings, PICCs are being embedded into chronic disease management frameworks, supported by telehealth monitoring and home care nursing - extending the reach of central venous access beyond the hospital walls.
Additionally, the global trend toward reducing hospital stays and shifting care to outpatient or home-based models is accelerating PICC placement across a broader patient base. Health systems focused on cost containment, patient-centered care, and infection prevention are prioritizing PICCs for their clinical and economic advantages. With the convergence of portable imaging, real-time placement guidance, and catheter material innovation, the PICC market is set to expand as a cornerstone of modern intravenous access strategies in both developed and emerging economies.
Global Peripherally Inserted Central Catheters Market - Key Trends & Drivers Summarized
Why Are Peripherally Inserted Central Catheters Gaining Preference Over Conventional Central Lines?
Peripherally Inserted Central Catheters (PICCs) are witnessing increased clinical adoption due to their minimally invasive nature and versatility in delivering long-term intravenous therapies. Unlike traditional central venous catheters that require insertion in the subclavian or jugular vein, PICCs are inserted into peripheral veins (typically in the arm) and advanced to the superior vena cava, offering a safer and more accessible route for infusion therapy. This advantage is particularly crucial for patients undergoing chemotherapy, parenteral nutrition, or extended antibiotic regimens, where long-term vascular access is essential.One of the key shifts favoring PICCs is their ability to be inserted at the bedside by specially trained nursing staff, eliminating the need for surgical suite occupancy and reducing procedural delays. Additionally, ultrasound and ECG-guided placement technologies have significantly enhanced insertion accuracy and safety, minimizing complications such as pneumothorax, arterial puncture, and catheter malposition. These benefits, combined with lower insertion costs and improved patient comfort, are propelling PICCs as the preferred vascular access method in both inpatient and outpatient care settings.
How Are Infection Control Standards, Antimicrobial Technologies, and Patient Stratification Redefining PICC Use?
The global focus on infection prevention in clinical care is placing significant emphasis on catheter-associated bloodstream infection (CABSI) reduction. PICC manufacturers are responding with advanced catheter materials embedded with antimicrobial coatings such as chlorhexidine, silver ions, or rifampin-minocycline combinations. These coatings not only reduce bacterial colonization but also extend dwell time, making PICCs more reliable for long-term use in immunocompromised and critically ill patients.Stratified care pathways are also influencing PICC usage patterns. In oncology, PICCs offer a central line alternative that reduces the risk of thrombosis and facilitates outpatient chemotherapy regimens. In home infusion therapy, patients with chronic infections or gastrointestinal disorders are now managed via PICCs supported by mobile care teams, improving continuity and reducing hospital readmission rates. Clinical algorithms based on dwell time, infusion type, and venous condition are increasingly guiding vascular access decisions, leading to more targeted and efficient use of PICCs.
Why Are Technological Advancements and Integrated Care Models Expanding Market Adoption?
Innovations in catheter design and placement are enhancing clinical outcomes and procedural workflow. Power-injectable PICCs capable of withstanding high flow rates are gaining popularity in diagnostic imaging and contrast-based interventions. Additionally, the introduction of pressure-sensitive valves, biofilm-resistant polymers, and securement devices is minimizing the risk of catheter dislodgment, occlusion, and infection - leading to fewer complications and improved patient outcomes.Integrated care models are also playing a key role in expanding the PICC market. Hospitals are establishing dedicated vascular access teams that streamline PICC placement, maintenance, and removal protocols, thus standardizing best practices and reducing complication rates. In ambulatory care and long-term acute care settings, PICCs are being embedded into chronic disease management frameworks, supported by telehealth monitoring and home care nursing - extending the reach of central venous access beyond the hospital walls.
What’s Driving the Growth of the Peripherally Inserted Central Catheters Market Worldwide?
The growth in the peripherally inserted central catheters market is driven by several factors including the increasing need for long-term intravenous therapy, rising healthcare decentralization, and advancements in infection control technologies. A primary growth driver is the growing population of cancer patients, individuals with chronic infections, and elderly patients who require safe, repeatable, and extended vascular access solutions.Additionally, the global trend toward reducing hospital stays and shifting care to outpatient or home-based models is accelerating PICC placement across a broader patient base. Health systems focused on cost containment, patient-centered care, and infection prevention are prioritizing PICCs for their clinical and economic advantages. With the convergence of portable imaging, real-time placement guidance, and catheter material innovation, the PICC market is set to expand as a cornerstone of modern intravenous access strategies in both developed and emerging economies.
Report Scope
The report analyzes the Peripherally Inserted Central Catheters market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:- Segments: Product Type (Conventional PICC, Power Injected PICC, Neonatal PICC); Lumen Type (Single Lumen, Double Lumen, Multiple Lumen); Application (Chemotherapy, Long-Term Iv Infusion, Parenteral Nutrition, Blood Transfusion, Difficult Intravenous Access, Other Applications); End-Use (Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings, Other End-Uses)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Conventional PICC segment, which is expected to reach US$684.1 Million by 2032 with a CAGR of a 3.7%. The Power Injected PICC segment is also set to grow at 2.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $236.6 Million in 2025, and China, forecasted to grow at an impressive 5.8% CAGR to reach $215.7 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Peripherally Inserted Central Catheters Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peripherally Inserted Central Catheters Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Peripherally Inserted Central Catheters Market expected to evolve by 2032?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2032?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Access Vascular, Inc., AngioDynamics Inc., Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the companies featured in this Peripherally Inserted Central Catheters market report include:
- Access Vascular, Inc.
- AngioDynamics Inc.
- Argon Medical Devices, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical Inc.
- Health Line Medical Products
- ICU Medical, Inc.
- Kimal Plc
- Medical Components, Inc.
- Medtronic plc
- Merit Medical Systems, Inc.
- PFM Medical, Inc.
- Poly Medicure Ltd.
- Teleflex Incorporated
- Utah Medical Products, Inc.
- Vygon SA
- Zhejiang Haolang Technology Co., Ltd.
What Sets This Report Apart From Others?
- Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
- Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
- Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
- Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
- Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
- Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Access Vascular, Inc.
- AngioDynamics Inc.
- Argon Medical Devices, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical Inc.
- Health Line Medical Products
- ICU Medical, Inc.
- Kimal Plc
- Medical Components, Inc.
- Medtronic plc
- Merit Medical Systems, Inc.
- PFM Medical, Inc.
- Poly Medicure Ltd.
- Teleflex Incorporated
- Utah Medical Products, Inc.
- Vygon SA
- Zhejiang Haolang Technology Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 492 |
| Published | October 2026 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 868.3 Million |
| Forecasted Market Value ( USD | $ 1100 Million |
| Compound Annual Growth Rate | 3.3% |
| Regions Covered | Global |
